New Data Show Ceftobiprole As Effective As Combination Therapy In Treating Patients With Complicated Skin Infections, Incluiding Area
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., announced that the investigational antibiotic ceftobiprole was as effective as commonly used combination therapy in treating patients with complicated skin infections caused by a broad spectrum of bacteria. Ceftobiprole also was found to clinically cure more than 90% of patients who had infections caused by Staphylococcus aureus (S.
